Mechanical calf compression and aspirin prophylaxis for total knee arthroplasty

Clinical Orthopaedics and Related Research

Volumn 464, Issue , 2007, Pages 61-64

  Lachiewicz, Paul F ^a,b   Soileau, Elizabeth S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTITHROMBOCYTIC AGENT;

ADULT; ARTERY THROMBOSIS; BIOMECHANICS; CLINICAL PROTOCOL; COMPRESSION; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPLITEAL ARTERY; PRIORITY JOURNAL; PROPHYLAXIS; REGIONAL ANESTHESIA; THROMBOEMBOLISM; TOTAL KNEE REPLACEMENT; AGED; ARTICLE; CLINICAL TRIAL; FEMORAL VEIN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; KNEE ARTHROPLASTY; LEG; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; POPLITEAL VEIN; POSTOPERATIVE COMPLICATION; PREVALENCE; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; ASPIRIN; COMBINED MODALITY THERAPY; FEMALE; FEMORAL VEIN; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; LEG; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POPLITEAL VEIN; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 35848954539     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e3181468951     Document Type: Conference Paper

References (20)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ. 1994;308:235-246.
2. Callaghan JJ, Dorr LD, Engh GA, Hanssen AD, Healy WL, Lachiewicz PF, Lonner JH, Lotke PA, Ranawat CS, Ritter MA, Salvati EA, Sculco TP, Thornhill TS. Prophylaxis for thromboembolic disease: recommendations from the American College of Chest Physicians - are they appropriate for orthopaedic surgery? J Arthroplasty. 2005;20:273-274.
3. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:338S-400S.
4. Grady-Benson JC, Oishi CS, Hanson PB, Colwell CW, Otis SM, Walker RH. Postoperative surveillance for deep vein thrombosis with duplex ultrasonography after total knee arthroplasty. J Bone Joint Surg Am. 1994;76:1649-1657.
5. Haas SB, Insall JN, Scuderi GR, Windsor RE, Ghelman B. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am. 1990;72:27-31.
6. Hooker JA, Lachiewicz PF, Kelley SS. Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty. J Bone Joint Surg Am. 1999;81:690-696.
7. Jaques PF, Richey WA, Ely CA, Johnson G Jr. Doppler ultrasonic screening prior to venography for deep vein thrombosis. AJR Am J Roentgenol. 1977;129:451-452.
8. Lachiewicz PF. The role of continuous passive motion after total knee arthroplasty. Clin Orthop Relat Res. 2000;380:144-150.
9. Lachiewicz PF, Kelley SS, Haden LR. Two mechanical devices for prophylaxis of thromboembolism after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br. 2004;86:1137-1141.
10. Lachiewicz PF, Soileau ES. Multimodal prophylaxis for THA with mechanical compression. Clin Orthop Relat Res. 2006;453:225-230.
11. Lonner JH. Thromboembolic disease in total knee arthroplasty. Am J Knee Surg. 1999;12:43-48.
12. Lotke PA, Lonner JH. The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty. Clin Orthop Relat Res. 2006;452:175-180.
13. Maynard MJ, Sculco TP, Ghelman B. Progression and regression of deep vein thrombosis after total knee arthroplasty. Clin Orthop Relat Res. 1991;273:125-130.
14. McCardel BR, Lachiewicz PF, Jones K. Aspirin prophylaxis and surveillance of pulmonary embolism and deep vein thrombosis in total hip arthroplasty. J Arthroplasty. 1990;5:181-185.
15. Poole MA, Keagy BA, O'Neill DA, Johnson G. A prospective evaluation of routine venous Doppler studies following major orthopaedic operations of the lower extremity. Bruit. 1984;8:42-44.
16. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet. 2000;355:1295-1302.
17. Silbersack Y, Taute BM, Hein W, Podhaisky H. Prevention of deep vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. J Bone Joint Surg Br. 2004;86:809-812.
18. Westrich GH, Bottner F, Windsor RE, Laskin RS, Haas SB, Sculco TP. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. J Arthroplasty. 2006;21(suppl 2):139-143.
19. Westrich GH, Sculco TP. Prophylaxis against deep vein thrombosis after total knee arthroplasty: pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg Am. 1996;78:826-834.
20. Westrich GH, Specht LM, Sharrock NE, Windsor RE, Sculco TP, Haas SB, Trombley JF, Peterson M. Venous haemodynamics after total knee arthroplasty: evaluation of active dorsal to plantar flexion and several mechanical compression devices. J Bone Joint Surg Br. 1998;80:1057-1064.